Drug profile · INN
salmeterol
SEFFALAIR SPIROMAX
salmeterol (SEFFALAIR SPIROMAX) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH.
EMA: approved Respiratory system (R03) R03AK06
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — salmeterol
- Class
- Respiratory system (R03)
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.89
Quick answer
salmeterol (SEFFALAIR SPIROMAX) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH.
Key facts
INN salmeterol
Brand SEFFALAIR SPIROMAX
Mechanism Beta-2 adrenergic receptor agonist
Therapeutic class Respiratory system (R03)
ATC code R03AK06
Originator Teva Pharma GmbH
Mechanism of action
Beta-2 adrenergic receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is salmeterol?
salmeterol (SEFFALAIR SPIROMAX) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH.
What is the brand name for salmeterol?
SEFFALAIR SPIROMAX is a marketed brand name for salmeterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.